For the Inventor, By the Inventor

Enter assignee name

Tottori University

USPTO Granted Patents = 61

% Expired Patents = 31.1

EPO Patents = 1

Forward Citations = 436

Loading Chart...

Loading Chart...

164 inventors (with patents filed for the assignee):

Norimasa Miura (6 out of 6 patents)

Mitsuo Oshimura (6 out of 14 patents)

Yasuhiro Kazuki (6 out of 8 patents)

4. Takafumi Nakamura (4 out of 6 patents)

5. Toru Sato (4 out of 11 patents)

6. Tetsuya Ohbayashi (3 out of 3 patents)

7. Yasushi Kuromi (3 out of 4 patents)

8. Masayoshi Kobayashi (3 out of 12 patents)

9. Takeshi Nishino (3 out of 31 patents)

10. Shinsuke Kato (3 out of 3 patents)

11. Goshi Shiota (3 out of 5 patents)

12. Noriko Itaba (3 out of 4 patents)

13. Masaru Ueki (3 out of 3 patents)

14. Yuhei Matsubara (3 out of 3 patents)

15. Yoshiharu Okamoto (3 out of 3 patents)

Core Competencies:

Endophyte Screening

Human Antibody

Dementia Drug

Image Processing

Cancer Inhibition

Chimeric Animal

Biomaterials

Gene Expression

Diagnostic Kit

Bioethanol Production

Nanofibers

Zeolite Catalyst

61 patents: Sort by Forward Citations

1. 12089547 - Endophyte screening (2024-09-17),

2. 12063913 - Human antibody-producing non-human animal and method for preparing human antibodies using same (2024-08-20),

3. 12060374 - Silyl ether-containing sulfonate salt (2024-08-13),

4. 11900509 - Image processing method for a computer to assist a user in assessment of a cultured embryo (2024-02-13),

5. 11866483 - Fibrosis-inhibiting composition, cells producing same, and cell sheet comprising said cells (2024-01-09),

6. 11825817 - Rat model of down syndrome and method for producing same (2023-11-28),

7. 11710237 - Image processing method and recording medium (2023-07-25),

8. 11485644 - MWW type zeolite, method for producing same, and cracking catalyst (2022-11-01),

9. 11369270 - Method of evaluating three-dimensional cell-based structure and method of evaluating medicinal effect (2022-06-28),

10. 11344589 - Genetically engineered vaccinia viruses (2022-05-31),

11. 11344539 - Therapeutic or prophylactic drug for dementia (2022-05-31),

12. 11213527 - Inhibitory effect of low molecular weight compound on cancer and fibrosis (2022-01-04),

13. 11065606 - Metal-substituted beta zeolite and method for producing same (2021-07-20),

14. 10888594 - Genetically engineered vaccinia viruses (2021-01-12),

15. 10842431 - Mental illness determination device (2020-11-24),

Company Overview

Tottori University, located in Tottori, Japan, is a prominent institution specializing in biomedical engineering. The university focuses on a diverse range of core technology topics, including endophyte screening, human antibody development, and innovative approaches to dementia treatment. Its research extends to image processing, cancer inhibition strategies, chimeric animal studies, biomaterials, and gene expression analysis. Tottori University is dedicated to advancing scientific knowledge and fostering collaboration in the biomedical field.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

61 Patents

#2 in Tottori

#1,512 in Japan

#11,930 in the World

Tottori University

Forward Citations = 436

164 inventors:

Norimasa Miura (6 out of 6 patents)

Mitsuo Oshimura (6 out of 14 patents)

Yasuhiro Kazuki (6 out of 8 patents)

4. Takafumi Nakamura (4 out of 6 patents)

5. Toru Sato (4 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tottori University. Retrieved from https://idiyas.com/company/tottori-university

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…